VAM
AZN icon

Verity Asset Management’s AstraZeneca AZN Stock Holding History

Verity Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$332K Buy
1,683
+90
+6% +$17.4K 0.14% 171
2025
Q4 		$293K Sell
1,593
-1,054
-40% -$185K 0.13% 190
2025
Q3 		$406K Buy
+2,647
New +$401K 0.13% 160

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Verity Asset Management's AZN Position: Q1 2026 in Review

Verity Asset Management increased its AstraZeneca (AZN) stake by 5.6% in Q1 2026, buying an estimated $17.4K and bringing the position to 1,683 shares worth $332K. The position accounts for 0.14% of the portfolio, ranked #171.

Verity Asset Management first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. The position peaked at $406K in Q3 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Verity Asset Management held 1,683 shares of AstraZeneca worth $332K as of Q1 2026.
  • Verity Asset Management bought 90 AstraZeneca shares in Q1 2026, an estimated $17.4K.
  • AstraZeneca made up 0.14% of Verity Asset Management's portfolio in Q1 2026, its #171 holding.
  • Verity Asset Management first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • Verity Asset Management's AstraZeneca position peaked at $406K in Q3 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.